)-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE - NEW NUCLEOSIDE ANALOGS WITH A BROAD-SPECTRUM ANTIVIRAL ACTIVITY
Yl. Qiu et al., )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE - NEW NUCLEOSIDE ANALOGS WITH A BROAD-SPECTRUM ANTIVIRAL ACTIVITY, Journal of medicinal chemistry, 41(1), 1998, pp. 10-23
New nucleoside analogues 14-17 based on a methylenecyclopropane struct
ure were synthesized and evaluated for antiviral activity. Reaction of
2,3-dibromopropene (19) with adenine (18) led to bromoalkene 20, whic
h was benzoylated to give N-6,N-6-dibenzoyl derivative 23. Attempts to
convert 20 or 23 to bromocyclopropanes 21 and 22 by reaction with eth
yl diazoacetate catalyzed by Rh-2(OAc)(4) were futile. By contrast, 2,
3-dibromopropene (19) afforded smoothly (E)- and (Z)-dibromocyclopropa
ne carboxylic esters 24 + 25. Alkylation of adenine (18) with 24 + 25
gave (E)- and (Z)-bromo derivatives 21 + 22. Base-catalyzed eliminatio
n of HBr resulted in the formation of (Z)- and (E)-methylenecyclopropa
necarboxylic esters 26 + 27. More convenient one-pot alkylation-elimin
ation of adenine (18) or 2-amino-6-chloropurine (30) with 24 + 25 affo
rded (Z)- and (E)-methylenecyclopropane derivatives 26 + 27 and 31 + 3
2. The Z-isomers were always predominant in these mixtures (Z/E simila
r to 2/1). Reduction of 26 + 27 and 31 + 32 with DIBALH afforded (Z)-
and (E)-methylenecyclopropane alcohols 14 + 16 and 33 + 34. The latter
were resolved directly by chromatography. Compounds 14 + 16 were conv
erted to N-6-(dimethylamino)methylene derivatives 28 and 29 which were
separated and deprotected to give 14 and 16. Reaction of 33 and 34 wi
th HCO2H led to guanine analogues 15 and 17. The H-1 NMR spectra of th
e Z-analogues 14 and 15 are consistent with an anti-like conformation
of the nucleobases. By contrast, H-1 NMR and IR spectra of bromo ester
21 are indicative of syn-conformation of adenine. Several Z-(hydroxym
ethyl)methylenecyclopropanes exhibited in vitro antiviral activity in
micromolar or submicromolar range against human and murine cytomegalov
irus (HCMV and MCMV), Epstein-Barr virus (EBV), human herpes virus 6 (
HHV-6), varicella tester virus (VZV), and hepatitis B virus (HBV). Ana
logues 14, 15, and 33 were the most effective agents against HCMV (IC5
0 1-2.1, 0.04-2.1, and 0.8-5.6 mu M), MCMV (IC50 2.1, 0.3, and 0.3 mu
M) and EBV in H-1 (IC50 0.2, 0.3, and 0.7 mu M) and Daudi cells (IC50
3.2, 5.6, and 1.2 mu M). Adenine analogue 14 was active against HBV (I
C50 2 mu M), VZV (IC50 2.5 mu M), and HHV-6 (IC50 14 mu M). Synadenol
(14) and the E-isomer (16) were substrates of moderate efficiency for
adenosine deaminase from calf intestine. The E-isomer 16 was more reac
tive than Z-isomer 14. The deamination of 14 effectively stopped at 50
% conversion. Synadenol (14) was also deaminated by AMP deaminase from
aspergillus sp.